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Key points
 In lean individuals, 6 weeks of extended morning fasting increases the expression of genes
involved in lipid turnover (ACADM) and insulin signalling (IRS2) in subcutaneous abdominal
adipose tissue.
 In obese individuals, 6 weeks of extended morning fasting increases IRS2 expression in sub-
cutaneous abdominal adipose tissue.
 The content and activation status of key proteins involved in insulin signalling and glucose
transport (GLUT4, Akt1 and Akt2) were unaffected by extended morning fasting. Therefore,
any observations of altered adipose tissue insulin sensitivity with extended morning fasting do
not necessarily require changes in insulin signalling proximal to Akt.
 Insulin-stimulated adipose tissue glucose uptake rates are lower in obese versus lean individuals,
but this difference is abolished when values are normalised to whole-body fat mass. This
suggests a novel hypothesis which proposes that the reduced adipose glucose uptake in obesity
is a physiological down-regulation to prevent excessive de novo lipogenesis.
Abstract This study assessed molecular responses of human subcutaneous abdominal adipose
tissue (SCAT) to 6 weeks of morning fasting. Forty-nine healthy lean (n= 29) and obese (n= 20)
adults provided SCAT biopsies before and after 6 weeks of morning fasting (FAST; 0 kcal until
12.00 h) or daily breakfast consumption (BFAST; 700 kcal before 11.00 h). Biopsies were
analysed for mRNA levels of selected genes, and GLUT4 and Akt protein content. Basal and
insulin-stimulated Akt activation and tissue glucose uptake rates were also determined. In lean
individuals, lipid turnover and insulin signalling genes (ACADM and IRS2) were up-regulated
with FAST versus BFAST (ACADM: 1.14 (95% CI: 0.97–1.30) versus 0.80 (95% CI: 0.64–0.96),
P= 0.007; IRS2: 1.75 (95%CI: 1.33–2.16) versus 1.09 (95%CI: 0.67–1.51), P= 0.03, respectively).
In obese individuals, no differential (FAST versus BFAST) expression was observed in genes
involved in lipid turnover (all P > 0.1). GLUT4, Akt protein content and insulin-stimulated
Akt phosphorylation were unaffected by FAST versus BFAST in both lean and obese cohorts (all
P > 0.1). Lower insulin-stimulated glucose uptake rates in obese versus lean individuals were
eradicated when normalised to whole-body fat mass (P = 0.416). We conclude that morning
fasting up-regulates lipid turnover genes in SCAT of lean individuals. Secondly, altered SCAT
insulin sensitivity with morning fasting is unlikely to be explained by signalling proximal to Akt.
Finally, lower insulin-stimulated SCAT glucose uptake rates in obese individuals are proportional
to whole-body fat mass, suggesting a compensatory down-regulation, presumably to prevent
excessive de novo lipogenesis in adipose tissue. This trial was registered as ISRCTN31521726.
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Introduction
Adipose tissue was once considered an inert storage depot,
but an understanding of its active roles inmetabolic health
is gaining momentum (Thompson et al. 2012). Adipose
tissue is dynamic, buffering daily lipid flux and regulating
glucose and lipid metabolism (Garg, 2011; Stanford
et al. 2015), inflammation, and hormone production
(Thompson et al. 2012). Importantly, insulin action in
adipocytes plays a major role in whole-body insulin
sensitivity (Abel et al. 2001) and thus adipose tissue is
viewed as a key target for metabolic control.
Subcutaneous adipose tissue is the primary site
of storage and release of fatty acids to the systemic
circulation (Koutsari & Jensen, 2006). Adipose tissue
physiology is highly responsive to acute alterations
in energy flux, such as those resulting from fasting,
feeding and physical activity (Ruge et al. 2009). The
acute switch in subcutaneous abdominal adipose tissue
(SCAT) metabolism from fasting to feeding results in
large changes in glucose and fatty acid flux (Ruge et al.
2009). This is partly co-ordinated by insulin signalling
and subsequent translocation of glucose transport
proteins and lipoprotein lipase activation (Ruge et al.
2009; Chen et al. 2017). It is notable that the SCAT
response to fasting versus feeding is profoundly blunted
in obesity. The postprandial increase in glucose and fatty
acid uptake by SCAT in obese individuals is less than
half that seen in lean individuals (McQuaid et al. 2011).
This dysregulation of glucose and fatty acid uptake by
adipose tissue in obesity is also accompanied by a lower
mRNA expression of genes involved in insulin signalling
(IRS2), glucose transport (GLUT4) (Travers et al. 2017)
and fatty acid metabolism (ACLS1, LPL, AGPAT9, PLIN,
HSL, PNPL2, DGAT1 and DGAT2; McQuaid et al. 2011;
Travers et al. 2017), with a concomitant increase inmRNA
expression of genes relating to inflammation/cytokine
signalling (IL1RA, IL-18 andMCP-1; Travers et al. 2017).
While much is known about the distinct metabolic and
molecular responses of SCAT to an acute feeding stimulus
in both lean and obese individuals, the chronic molecular
adaptations of SCAT to modified fasting and feeding
patterns have never been assessed in either lean or obese
individuals.
The Bath Breakfast Projectwas a randomised controlled
trial comparing extended morning fasting (0 kcal until
12.00 h) with daily breakfast consumption (700 kcal
before 11.00 h) in healthy lean and obese adults (Betts
et al. 2011). Compared to daily breakfast consumption,
extended morning fasting impaired glucose control in
SCAT in lean, but not obese, individuals (Betts et al. 2014;
Chowdhury et al. 2016a). Specifically, extended morning
fasting in lean individuals increased in vivo SCAT inter-
stitial glucose variability in the afternoon and evening
(Betts et al. 2014) and ex vivo, an index of SCAT insulin
sensitivity increased from baseline to follow-up in the
breakfast group, but not in the fasting group (Betts et al.
2014). Importantly, these findings were not observed in
an obese cohort (Chowdhury et al. 2016a). Furthermore
SCAT from obese individuals displayed quantitatively
lower rates of insulin-stimulated glucose uptake
(expressedpermilligram lipid) compared to that from lean
individuals both at physiological, and supraphysiological
insulin concentrations (Chowdhury et al. 2016a).
Differences in insulin-stimulated (physiological and/or
maximal) glucose uptake by adipose tissue could be
explained by differences in GLUT4 content and/or
alterations in insulin signalling and GLUT4 translocation
(Tan et al. 2015; Travers et al. 2015). For example, adipose
tissue from individuals who are obese or have type
2 diabetes displays reduced insulin-stimulated glucose
uptake, alongside a 40–85% reduction in GLUT4 protein
content (Garvey et al. 1991). The lower GLUT4 protein
content is thought to be regulated at the mRNA level, as
GLUT4 mRNA expression shows a progressive decrease
across the range from lean to obese (Travers et al. 2015).
Akt (PKB) is a key insulin signalling protein that is
essential for most metabolic actions of insulin, including
phosphorylation of TBC1D4/AS160 leading to GLUT4
translocation (Kane et al. 2002; Tan et al. 2012). Defects in
signalling proximal toAkt have been identified as potential
contributors to insulin resistance in various models (Tan
et al. 2015). We therefore focused on GLUT4 content, Akt
signalling and gene expression in SCAT to elucidate the
mechanisms that regulate adipose tissue adaptations over
6 weeks of extended morning fasting compared to regular
breakfast consumption in lean and obese individuals.
Methods
Ethical approval
This study adhered to the standards set by theDeclaration
ofHelsinki and the procedures followedwere in accordance
with the protocol approved by the National Health Service
South-West 3 Research Ethics Committee (10/H0106/13).
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Table 1. Whole-body characteristics at baseline in lean and obese individuals who donated adipose tissue biopsiese
Characteristic Lean cohort (n = 29) Obese cohort (n = 20) P
Age (years) 36 ± 11 43 ± 10 0.033k
Female (n (%)) 21 (64%) 13 (65%) —
Frequent habitual breakfast consumera (n (%)) 26 (79%) 13 (65%) —
Height (m) 1.71 ± 0.07 1.71 ± 0.10 0.566l
Body mass (kg) PRE 66.2 ± 8.3 98.5 ± 20.1 0.001k
Lean mass (DXAb)f (kg) PRE 45.9 ± 8.4 53.5 ± 8.9 0.003k
Adipose tissue mass (DXA)f (kg) PRE 17.3 ± 5.5 37.8 ± 10.0 0.001k
Body mass index (kg m−2) PRE 22.6 ± 2.3 33.6 ± 5.0 0.001k
Fat mass indexf (DXAc) (kg m−2) PRE 6.0 ± 2.1 13.3 ± 4.0 0.001k
Per cent body fatf (DXA) PRE 26.4 ± 7.8 40.0 ± 7.3 0.001l
Resting metabolic rateg (kcal day−1) PRE 1435 ± 187 1656 ± 296 0.006l
Fasting RER PRE 0.81 ± 0.06 0.83 ± 0.06 0.358l
Fasting glucosef,h (mmol L−1) PRE 5.35 ± 0.30 5.43 ± 0.38 0.589l
Fasting insulinf,h (pmol L−1) PRE 22.8 ± 9.6 59.1 ± 27.5 0.001k
C-ISI Matsuda indexd,i PRE 9.9 ± 6.7 3.9 ± 1.7 0.001k
Fasting NEFAi (mmol L−1) PRE 0.60 ± 0.25 0.53 ± 0.24 0.421k
Data are means ± SD unless otherwise stated. aDefined as the ingestion of 50 kcal within 2 h of waking on most days of the
week. bLean tissue mass excludes bone mineral content. cDXA-derived fat mass index obese ranges (Kelly et al. 2009) are 13 kg m−2
(females) and 9 kg m−2 (males). dC-ISI Matsuda index = 1000/[fasted glucose (mg dL−1) × fasted insulin (μIU mL−1)] × [mean
glucose over 120 min OGTT (mg dL−1) × mean insulin over 120 min OGTT (μIU mL−1)]. eData presented are comparisons of lean and
obese participants from Betts et al. (2014) and Chowdhury et al. (2016a). fn = 19 for obese. gn = 28 for lean. hn = 24 for lean. in = 23
for lean and n = 16 for obese. jn = 17 for obese. kMann–Whitney test; lunpaired t test. DXA, dual-energy X-ray absorptiometry;
NEFA, non-esterified fatty acid.
All participants provided informed written consent prior
to participation in the study.
Experimental design
The Bath Breakfast Project is a randomised controlled
trial registered with Current Controlled Trials
(ISRCTN31521726) and the protocol has been published
in full (Betts et al. 2011), with trial enrolment, base-
line/eligibility testing, allocation and follow-up all con-
ducted in accordance with CONSORT guidelines (Schulz
et al. 2010). A CONSORT flow diagram, along with
precise details of this protocol and the rationale for our
approach/methods have previously been published (Betts
et al. 2011, 2014). Demographic, anthropometric and
physiological characteristics of those who completed the
trial are presented in Table 1. This cohort completed
intensive laboratory-based assessments at baseline and
we have previously reported resting metabolic rate (via
indirect calorimetry from gaseous exchange), anthro-
pometric characteristics (i.e. bodymass and DXA-derived
body composition (Discovery W bone densitometer,
Hologic Inc., Marlborough, MA, USA)), and some
physiological characteristics (specifically, fasting plasma
glucose and insulin concentrations; composite Matsuda
insulin sensitivity index, adipose tissue glucose uptake
rates expressed per milligram lipid) (Betts et al. 2014;
Chowdhury et al. 2015, 2016a, b). We repeat these
data here for context in relation to the novel molecular
outcomes, and clearly indicate whenever data were
previously published.
Participants all met the following inclusion criteria:
aged 21–60 years; record of regular menstrual cycle/
contraceptive use (if relevant); no anticipated changes in
diet and/orphysical activityhabitsduring the studyperiod;
weight stable (within 2% over past 6 months); non-shift
workers; not pregnant or breastfeeding; and free from any
other condition or behaviour deemed either to pose undue
personal risk or introduce bias into the experiment.
While all participants in both groups remained in a 10 h
overnight fasted state (i.e. 09.00 ± 1 h), a small (1 g)
subcutaneous adipose tissue biopsy (1 g) was sampled
from the abdomen, 5 cm lateral to the umbilicus, by
needle aspiration (14 gauge) after local anaesthesia (4 mL,
1% lidocaine) as previously described (Walhin et al. 2013;
Travers et al. 2015). These were used to provide measures
of the post-absorptive protein content of GLUT4, Akt1
and Akt2, in addition to the mRNA expression of key
selected genes involved in adipose tissue metabolism and
inflammation. Furthermore, measures of adipose tissue
glucose uptake and Akt phosphorylation were performed
under basal and insulin-stimulated conditions.
These measures were followed up 6 weeks later,
along with continuous (5 min sampling interval)
monitoring of interstitial glucose concentrations via
a subcutaneous abdominal catheter (iPro, Medtronic,
Watford, United Kingdom) both to document chronic
glycaemic responses and to verify compliance, as reported
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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previously (Betts et al. 2014; Chowdhury et al. 2016a).
Eumenorrhoeic women provided baseline samples
2weeks prior to the start of the 6-week intervention so that
follow-up samples could be acquired 3–10 days after the
onset of menses (i.e. follicular phase). During the 6-week
intervention, participantswere randomised (1:1 allocation
ratio) into either a group prescribed a self-selected energy
intake of 700 kcal before 11.00 h daily, with at least half
consumedwithin 2 h of waking (BFAST group) or a group
to extend their overnight fast by abstaining from ingestion
of energy-providing nutrients (i.e. plain water only)
until 12.00 h each day (FAST group). The randomisation
schemewas generated by the principal investigator (J.A.B.)
using a computer-based random number generator and
was stratified according to baseline breakfast habits
(block size = 4), with frequent breakfast consumption
defined as the ingestion of  50 kcal within 2 h of
waking on most days of the week. Investigators enrolling
participants (J.D.R. and E.A.C.) were unaware of these
details and independently requested group assignments
to prevent deciphering of the allocation sequence. Due to
the self-administered nature of the treatments, it was not
possible to blind participants to group allocation. The
intervention was applied under free-living conditions
and all other lifestyle choices were allowed to vary
naturally. Compliance was confirmed via self-report and
verified via continuous glucose monitoring; data reported
herein are therefore only for those individuals for whom
baseline and follow-up measurements are available (i.e. a
completers-only analysis).
Glucose uptake and protein expression analysis
in isolated primary adipocytes
Adipose tissue biopsies were digested with collagenase
before determination of D-[U-14C]glucose uptake as pre-
viously described (Foley et al. 1983; Kashiwagi et al.
1983; Betts et al. 2011). The lipid content of adipocytes
was determined by extraction and weighing of total
lipids of a 50 μL aliquot of 20% adipocytes in
suspension. The cell suspension was mixed with 2.7 mL
of isopropanol:heptane:H2SO4 (40:10:1 ratio) followed by
the addition of 1.8 mL heptane and 1.0 mL of ddH2O
before vortexing and centrifugation. A 1.0 mL aliquot
of the organic layer was evaporated and the lipid sub-
sequently weighed.
Proteins were separated by SDS-PAGE and trans-
ferred using semidry electrotransfer to a nitrocellulose
membrane and were normalised to glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and per milligram
lipid within each sample. Western blotting analysis was
performedwith the following antibodies: Akt1 (Millipore,
Billerica, MA, USA), Akt2 (Millipore), phosphoserine
473 Akt (Cell Signaling Technology, Danvers, MA, USA),
GLUT4 (Holman et al. 1990), GAPDH (Proteintech,
Rosemont, IL, USA). The images were acquired in an EPI
Chemi II darkroom (UVP, Upland, CA, USA) and bands
quantified using VisionWorks LS analysis software (UVP).
RNA extraction and quantitative real-time PCR
Total RNA was extracted by the method of Chomczynski
& Sacchi (1987) using TRIzol reagent (Thermo Fisher
Scientific,Waltham,MA,USA).Quantification and purity
of RNA were assessed using Nanodrop ND-100 (Thermo
Fisher Scientific). Reverse transcription was carried out
using 500 ng of total RNA using the SuperScript III cDNA
kit (Invitrogen, Paisley, UK). TaqmanLowdensity Custom
Array using Micro Fluidic cards (Life Technologies,
Thermo Fisher Scientific) was used for the relative
quantification of expression of 48 genes as previously
described (Tsintzas et al. 2013). Each card allowed for
eight samples to be run in parallel against 48 Taqman gene
expression assay targets that were pre-loaded into each of
the wells on the card. A control sample was loaded in each
card to assess reproducibility of data between cards and
normalise for variations in the expression of the target
genes between cards. Briefly, 50 μL of Taqman Universal
PCR master mix (2×) (Life Technologies, Thermo Fisher
Scientific) was added to 200 ng RNA equivalent of cDNA
into anEppendorf RNAse-free tube. RNAse-freewaterwas
added tomake the total volume of the reactionmixture up
to 100 μL. The reaction mixture was mixed, centrifuged
and loaded into one of the fill reservoirs of the Micro
Fluidic card. The cards were centrifuged (Multifuge 3
S-R, Heraeus, Hanau, Germany) and run on a 7900HT
Fast Real-Time PCR System (Life Technologies, Thermo
Fisher Scientific). Relative quantification of the genes of
interest was performed using the comparativeCT method.
The geometric mean of three housekeeping genes (18S
ribosomal RNA (18S), PPIA and PGK1) was used to
normalise the data, as previously described (Tsintzas et al.
2013, 2017). These genes were selected a priori, based
on their stability in multiple adipose tissue/adipocyte
samples (Neville et al. 2011) and this was confirmed
in the present study using an algorithm as previously
described (Andersen et al. 2004). The normalisation
to multiple housekeeping genes was used to minimise
variations in the expression of individual housekeeping
genes (Vandesompele et al. 2002). One gene (UCP1;
uncoupling protein 1)was undetectable and therefore data
for 44 genes are presented (Table 2).
Statistical analyses
Statistical analyses were performed using SPSS Statistics
v. 24 (IBM Corp., Armonk, NY, USA) and Prism v. 7
(GraphPad Software, San Diego, CA, USA). Values are
means with 95% confidence intervals (CI) unless stated
otherwise and were checked for normal distribution by
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Table 2. Gene expression assay targets in human subcutaneous abdominal adipose tissue
Gene Protein/enzyme
18S rRNA 18S ribosomal RNA
ACACA Acetyl-CoA carboxylase alpha
ACADM Medium-chain acyl-coenzyme A dehydrogenase
ADIPOQ Adiponectin
AKT1 Akt; protein kinase B
AKT2 Akt; protein kinase B
ANGPTL4 Angiopoietin-like 4
CCL2 Chemokine (C-C motif) ligand 2
FABP4 Fatty acid binding protein 4
FASN Fatty acid synthase
FOXO1 Forkhead box protein 01
G6PD Glucose-6-phosphate dehydrogenase
HSD11B1 11β-hydroxysteroid dehydrogenase type 1
IL18 Interleukin 18
IL6 Interleukin 6
IRS1 Insulin receptor substrate 1
IRS2 Insulin receptor substrate 2
LEP Leptin
LIPE Hormone sensitive lipase
LPL Lipoprotein lipase
MLXIPL Carbohydrate-response element-binding protein
NAMPT Nicotinamide phosphoribosyltransferase
NFKB1 Nuclear factor NF-kappa-B p105 subunit
NFKB2 Nuclear factor NF-kappa-B p100 subunit
NR1H2 Liver X receptor-beta
NR1H3 Liver X receptor-alpha
PDK4 Pyruvate dehydrogenase kinase
PER2 PER2
PGK1 Phosphoglycerate kinase 1
PIK3R1 Phosphatidylinositol 3-kinase regulatory subunit alpha
PNPLA2 Adipose triglyceride lipase/palatin-like phospholipase domain-containing protein 2
PPARA Peroxisome proliferator-activated receptor alpha
PPARD Peroxisome proliferator-activated receptor delta
PPARGC1A Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
PPARG Peroxisome proliferator-activated receptor gamma
PPIA Peptidylprolyl isomerase A/cyclophilin A/rotamase A
PRKAA1 5′-AMP-activated protein kinase catalytic subunit alpha-1
PRKAA2 5′-AMP-activated protein kinase catalytic subunit alpha-2
RETN Resistin
SLC2A4 GLUT4 (glucose transporter type 4)
SREBF1 Sterol regulatory element-binding transcription factor 1; sterol regulatory element-binding protein 1
STAT5A Signal transducer and activator of transcription 5A
STAT5B Signal transducer and activator of transcription 5B
TBC1D4 AS160 (Akt substrate of 160 kDa); TBC1D4 (TBC1 domain family member 4)
TNF Tumor necrosis factor
UCP1 Mitochondrial uncoupling protein 1
UCP2 Mitochondrial uncoupling protein 2
UCP3 Mitochondrial uncoupling protein 3
the Shapiro–Wilk normality test prior to analysis. mRNA
expression is presented as means ± 95% CI in the first
instance (Figs 1 and 2), and secondly as effect sizes
from baseline to follow-up in a heat-map (Fig. 3). This
combination was chosen in order to capture both the
quantitative mRNA expression and the relative change
within the context of variability. The effect size (Cohen’s
d) was calculated as:
d = meanfollow-up – meanbaseline
SDpooled
C© 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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where:
SDpooled =
√
SDbaseline2 + SDfollow-up2
2
Differences between treatments (breakfast versus
fasting) were assessed by ANCOVA with baseline
scores as the covariate (Bland & Altman, 2015). The
phosphorylation status of Akt at basal and physiological
insulin concentrations was assessed by ANCOVA with
both treatment (breakfast versus fasting) and insulin
concentration (basal versus 50 pM) as fixed factors
and baseline scores as the covariate. All P-values have
been adjusted for multiple comparisons by Bonferroni
correction. Characteristics of lean and obese cohorts at
baseline were compared by Student’s paired t test or
Mann–Whitney test as appropriate. Since the a priori plan
of this studywas to assess lean andobese cohorts separately
(Betts et al. 2011), the responses of lean and obese
cohorts to the intervention were not statistically assessed,
and therefore inferences of each cohort’s responses
should be considered separately from one another.
Relationships between glucose uptake and GLUT4
protein content were assessed with Pearson’s correlation
coefficient.
Results
Relative post-absorptive mRNA expression pre- and
post-intervention
In lean individuals, the post-absorptive adipose tissue
mRNA expression of genes involved in lipid turnover and
theproximal components of the insulin signallingpathway
(ACADM and IRS2) was up-regulated with extended
morning fasting relative to regular breakfast consumption
in the lean cohort (P = 0.007 and 0.03, respectively;
Figs 1 and 3). However, there was no differential
(breakfast versus fasting) mRNA expression of four key
genes further downstream of PIK3R in lean individuals
(Fig. 3; all P > 0.1). The mRNA expression of genes
involved in AMPK signalling, inflammation/cytokine
signalling, and mitochondrial signalling was not affected
by extended morning fasting, compared to regular break-
fast consumption (all P > 0.1; Fig. 3).
5
PRE
POST
(FAST)
PRE
POST
(BFAST)
4
3
2
S
C
AT
 m
R
N
A
 c
on
te
nt
S
C
AT
 m
R
N
A
 c
on
te
nt
A
C
A
C
A
A
C
A
D
M
A
D
IP
O
Q
A
K
T1
A
K
T2
A
N
G
P
TL
4
C
C
L2
FA
B
P
4
FA
S
N
F
O
XO
1
G
6P
D
H
S
D
11
B
1
IL
18 IL
6
IL
6
IR
S
1
IR
S
2
LE
P
LI
P
E
LP
L
M
LX
IP
L
N
A
M
P
T
N
F
K
B
1
N
F
K
B
2
N
R
1H
2
N
R
1H
3
P
D
K
4
P
E
R
2
P
IK
3R
1
P
N
P
L
A
2
P
PA
R
A
P
PA
R
D
P
PA
R
G
C
1A
P
PA
R
G
P
R
K
A
A
1
P
R
K
A
A
2
R
E
TN
S
LC
2A
4
S
R
E
B
F
1
S
TA
T5
A
S
TA
T5
B
TB
C
1D
4
TN
F
U
C
P
2
U
C
P
3
A
C
A
C
A
A
C
A
D
M
A
D
IP
O
Q
A
K
T1
A
K
T2
A
N
G
P
TL
4
C
C
L2
FA
B
P
4
FA
S
N
F
O
XO
1
G
6P
D
H
S
D
11
B
1
IL
18
IR
S
1
IR
S
2
LE
P
LI
P
E
LP
L
M
LX
IP
L
N
A
M
P
T
N
F
K
B
1
N
F
K
B
2
N
R
1H
2
N
R
1H
3
P
D
K
4
P
E
R
2
P
IK
3R
1
P
N
P
L
A
2
P
PA
R
A
P
PA
R
D
P
PA
R
G
C
1A
P
PA
R
G
P
R
K
A
A
1
P
R
K
A
A
2
R
E
TN
S
LC
2A
4
S
R
E
B
F
1
S
TA
T5
A
S
TA
T5
B
TB
C
1D
4
TN
F
U
C
P
2
U
C
P
3
1
0
5
4
3
2
1
0
A
B
Figure 1. mRNA expression of 44 selected genes in subcutaneous abdominal adipose tissue of lean
humans randomised to extended morning fasting (FAST; n = 13; A) or regular breakfast consumption
(BFAST; n = 13; B) for 6 weeks
Values represent the ratios of the mRNA content of target genes to the geometric mean content of housekeeping
genes expressed as means ± 95% CI.
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In obese individuals, the post-absorptive adipose tissue
mRNA expression of genes involved in lipid turnover was
not affected by extended morning fasting versus regular
breakfast consumption (all P > 0.1; Figs 2 and 3). IRS2
mRNA expression was increased with extended morning
fasting versus regular breakfast consumption (P = 0.049;
Fig. 3); however, genes involved in insulin signalling
proximal to IRS2 displayed no differential regulation
by extended morning fasting versus regular breakfast
consumption in obese individuals (all P> 0.1; Fig. 3). The
mRNA expression of genes involved in AMPK signalling
and inflammation/cytokine signalling was unaffected by
extended morning fasting, compared to regular breakfast
consumption (all P > 0.1; Fig. 3).
GLUT4, Akt1 and Akt2 protein content
In lean individuals, the protein content of GLUT4, Akt1
and Akt2 was unaffected by extended morning fasting
compared to regular breakfast consumption, whether
expressed either per milligram lipid, or per milligram
lipid multiplied by adipose tissue mass (Fig. 4A and C;
all P > 0.1).
In obese individuals, the protein content of GLUT4,
Akt1 andAkt2wasunaffectedby extendedmorning fasting
compared to regular breakfast consumption, whether
expressed either per milligram lipid or per milligram
lipid multiplied by adipose tissue mass (Fig. 4B and D;
all P > 0.1).
Akt activation
In the lean cohort, Ser 473 phosphorylation of Akt
increased up to 50% of maximal response with physio-
logical concentrations of insulin (Fig. 5A, P = 0.011).
But there was no treatment (FAST versus BFAST), nor
any insulin × treatment interaction effect (P = 0.441 and
P = 0.725, respectively).
In the obese cohort, Ser 473 phosphorylation of Akt
increased with physiological concentrations of insulin
(Fig. 5B, P = 0.003. But there was no treatment (FAST
versus BFAST), nor any insulin × treatment interaction
effect (P = 0.627 and P = 0.909, respectively).
Adipose tissue glucose uptake
At baseline, GLUT4 levels were modestly positively
correlated with adipose tissue glucose uptake at physio-
logical insulin concentrations (i.e. 50 pM; Fig. 6A).
However, the baseline to follow-up change in GLUT4
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Figure 2. mRNA expression of 44 selected genes in subcutaneous abdominal adipose tissue of obese
humans randomised to extended morning fasting (FAST; n = 10; A) or regular breakfast consumption
(BFAST; n = 10; B) for 6 weeks
Values represent the ratios of the mRNA content of target genes to the geometric mean content of housekeeping
genes expressed as means ± 95% CI.
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protein content did not correlate with the change in
insulin-stimulated glucose uptake (Fig. 6B).
At baseline, adipose tissue glucose uptake under physio-
logical concentrations of insulin was 2.6-fold higher
in lean compared to obese individuals when expressed
per milligram lipid (Fig. 7A; difference between lean and
obese: 0.038 pmol min−1 (mg lipid)−1; P < 0.0001), as
previously reported without direct comparison between
lean and obese cohorts (Chowdhury et al. 2016a).
Furthermore, adipose tissue glucose uptake expressed per
milligram lipid negatively correlated with DXA-derived
whole-body fat mass (r = −0.480, P < 0.001). However,
once normalised for whole-body adipose tissue mass, the
difference in adipose tissue glucose uptake rates between
lean and obese cohorts was abolished (Fig. 7B; difference
between lean and obese: 0.148 pmolmin−1 (mg lipid)−1 ×
adipose tissue mass; P = 0.416).
Discussion
The present work is the first to examine the molecular
responses of human adipose tissue to extended morning
fasting. Six weeks of extended morning fasting alters the
post-absorptive mRNA expression of a number of meta-
bolic genes in human adipose tissue of lean individuals.
In particular, extended morning fasting increases the
post-absorptive expression of genes involved in lipid
turnover compared to daily breakfast consumption in
lean individuals. Furthermore, important regulators of
insulin sensitivity (e.g. IRS2) were also up-regulated by
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fasting versus breakfast consumption in lean individuals.
Extended morning fasting did not, however, alter
the protein content of GLUT4, Akt1 or Akt2, nor
insulin-induced Akt phosphorylation in either lean or
obese individuals. Whilst some previous studies have
characterised the response of lean and obese adipose
tissue to an acute feeding stimulus (McQuaid et al.
2011), the chronic molecular responses of human adipose
tissue to different feeding and fasting patterns had never
previously been assessed in either lean, nor in obese
individuals.
There is strong evidence that the protein content
of GLUT4 is an important contributory factor to the
reduction in human adipose tissue insulin sensitivity in
obesity and type 2 diabetes. GLUT4 content is typically
>40% lower in adipose tissue from individuals with
obesity and type 2 diabetes, when compared to lean
individuals, seemingly regulated at the mRNA level
(Garvey et al. 1991). In line with this, we observed that
the content of GLUT4 positively correlated with adipose
tissue glucose uptake at physiological concentrations of
insulin, thereby supporting the role of GLUT4 content
in adipose tissue insulin sensitivity. These reductions in
protein contentmay therefore contribute to the lower rates
of glucose uptake in adipose tissue from obese individuals
compared to lean individuals at both physiological and
maximal (Chowdhury et al. 2016a) insulin-stimulated
conditions.
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Whilst GLUT4 content is of importance in explaining
the alterations in insulin sensitivity with chronic changes
in fat mass, we did not observe changes in protein content
of GLUT4, Akt1 or Akt2 with extended morning fasting
compared to regular breakfast consumption, at the level
of either mRNA or protein. Therefore, changes in the
content of these proteins may not be necessary to explain
differences in adipose tissue glucose control with extended
morning fasting versus breakfast consumption in lean
individuals,whenenergybalance ismaintained (Betts et al.
2014). In support of this, the pre- to post-intervention
change in GLUT4 content did not correlate with the
change in insulin-stimulated glucose uptake. The lack of
an increase in post-absorptive GLUT4 and Akt mRNA
expression, and in GLUT4, Akt1 and Akt2 protein
content, suggests that phosphoprotein signalling leading
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fasting (FAST; n = 5 lean; n = 4 obese) or regular breakfast consumption (BFAST; n = 4 lean; n = 8
obese) for 6 weeks
Data are presented from measures under basal and physiological (50 pM) insulin concentrations as means ± 95%
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to increases in GLUT4 translocation and/or activity is
likely to be primarily responsible for the alterations in
adipose tissue glucose control previously observed with
extended morning fasting versus breakfast consumption
(Betts et al. 2014), rather thandenovo synthesis ofproximal
signalling proteins or GLUT4 proteins.
In order to assess whether activation of Akt could ex-
plain any adaptations in adipose tissue glucose control
with altered meal patterns, we assessed the phospho-
rylation status of Akt in human adipocytes under basal
and physiological (50 pM) insulin stimulation ex vivo. In
neither lean nor obese individuals did extended morning
fasting alter insulin-stimulated Akt phosphorylation
compared to regular breakfast consumption. This is
consistent withmurine data demonstrating that 28 days of
high fat diet induced-insulin resistance in adipose tissue
does not coincidewith a reduction inAkt phosphorylation
or in GLUT4 protein content, but rather with a reduction
in AS160 phosphorylation (Tan et al. 2015). Therefore, the
effects of fasting/feeding patterns on adipose tissue glucose
control in lean individuals are likely to be explained by
signalling downstream of Akt, but the precise location of
this regulation remains to be determined.
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Figure 7. Baseline adipose tissue glucose uptake at
physiological concentrations (50 pm) of insulin in lean (n = 29)
and obese (n = 18) humans expressed per mg lipid (A), or per
mg lipid multiplied by DXA-derived whole-body fat mass (B)
Horizontal lines represent means ± 95% CI. Differences between
lean and obese cohorts were compared by Mann–Whitney tests.
The lower insulin-stimulated adipose tissue glucose
uptakepermilligram lipid fromobese individuals reported
previously (Garvey et al. 1991; Chowdhury et al. 2016a)
could represent a physiological down-regulation of insulin
sensitivity. A physiological down-regulation of adipose
tissue non-esterified fatty acid (NEFA) release in obesity
has previously been suggested whereby, with increasing
adiposity, the down-regulation of NEFA release per
kilogram of adipose tissue preserves circulating NEFA
homeostasis (Karpe et al. 2011). Consistent with this,
obese participants in the present study did not display
elevated circulating plasma NEFA concentrations relative
to lean participants, in spite of more than two-fold
greater average fat mass. To explore whether this may also
be the case with insulin stimulated glucose uptake, we
multiplied the rate of glucose uptake (originally expressed
as pmolmin−1 (mg lipid−1)) byDXA-derivedwhole-body
adipose tissuemass (kg).Once normalised forwhole-body
fat mass, no differences in insulin-stimulated glucose
uptake were detected between lean and obese groups,
and the spread of data were remarkably similar between
these cohorts. It may therefore be that the reduction in
insulin-stimulated glucose uptake in obese (but otherwise
healthy) individuals is a physiological mechanism to limit
the absolute rate of glucose uptake by adipose tissue, and
thereby constrain the rate of de novo lipogenesis. In line
with this, others have demonstrated that individuals with
obesity have a higher proportion of adipocytes that are
refractory (rather than responsive) to insulin-stimulated
glucose uptake in vitro (Lizunov et al. 2015), and have
a lower adipose tissue expression of genes involves in
lipogenesis (Roberts et al. 2009). However, since our
finding was due to exploratory analysis, it should be
confirmed in future studies.
In an attempt to explore transcriptional changes that
could be chronically altered by changes in fasting and
feeding patterns, we also assessed themRNA expression of
selected genes involved in a number of signalling pathways
in the post-absorptive state before and after the inter-
vention. The post-absorptive expression of a gene involved
in lipid turnover (ACADM) was up-regulatedwith 6weeks
of extended morning fasting relative to daily breakfast
consumption, in lean individuals. These responses could
be expected since extended morning fasting results in
greater rates of whole-body lipid utilisation (Gonzalez
et al. 2013) which, both at rest and during low intensity
physical activity, is primarily supported by adipose
tissue-derivedNEFAs (van Loon et al. 2001). Interestingly,
these responses were not observed in the obese cohort.
Whilst no statistical comparison was made between
lean and obese responses to the intervention (due to a
priori decisions on power), ACACA expression tended to
respond in the opposite direction (i.e. down-regulated
with extended morning fasting versus daily breakfast
consumption). It may be that the obese cohort were
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less metabolically flexible than the lean cohort, and so
were mobilising and oxidising lipids to a lesser extent
than the lean cohort in the fasted state. Consistent with
this, the fasting whole-body respiratory exchange ratio
(RER) of the obese cohort at follow-up was higher than
the lean cohort (lean versus obese difference: −0.03,
P = 0.01). Importantly, this difference in RER is not
explained by differences in dietary carbohydrate intake,
since daily carbohydrate intake did not substantially differ
between lean and obese individuals when expressed in
absolute terms (lean: 292 (95% CI: 260–323) g day−1;
obese: 283 (95% CI: 241–326) g day−1, P = 0.531),
and was therefore higher in lean versus obese individuals
when expressed relative to body mass (lean: 4.4 (95%
CI: 3.9–4.9 g day−1 (kg BM)−1); obese: 2.9 (95% CI:
2.6–3.3) g day−1 (kg BM)−1, P < 0.001) (Betts et al. 2014;
Chowdhury et al. 2016a).
Lean individuals demonstrated an up-regulated post-
absorptive mRNA expression of genes involved in the
early phases of insulin signalling (e.g. IRS2) with extended
morning fasting, when compared to daily breakfast
consumption. However, such changes were not evident in
more distal components of the insulin signalling cascade
(e.g. AKT, FOXO1 or TBC1D4). Obese individuals also
demonstrated an up-regulation of IRS2. These findings
are consistentwith acute studies in humans,where adipose
tissue IRS2mRNAexpression is up-regulatedwith exercise
performed in an overnight fasted state, compared to
in the fed state (Chen et al. 2017) and skeletal muscle
PI3KR1 mRNA expression robustly increases in response
tometabolic challenges such as hyperinsulinaemia, hyper-
glycaemia and exercise (Tsintzas et al. 2013, 2017). Since
PI3KR is known to negatively correlate with proximal
insulin signalling under specific metabolic conditions
(Barbour et al. 2005; Brachmann et al. 2005), the trend
for an increase in adipose tissue PI3KR1 expression with
extended morning fasting in lean individuals is consistent
with reduced adipose tissue glucose control. The finding
that PI3KR1 did not respond to extended morning fasting
compared to regular breakfast consumption in obese
individuals is likely to be explained by the presence of
existing insulin resistance in the adipose tissue of these
individuals. This is also consistent with the findings from
our previous work demonstrating that extended morning
fasting did not alter adipose tissue glucose control in obese
individuals (Chowdhury et al. 2016a).
It could be considered surprising that mitochondrial
genes did not display a differential expression with break-
fast consumption versus fasting, given that the break-
fast group had higher physical activity levels (Betts et al.
2014). Physical activity is known to acutely increasemRNA
expression of various genes relating to mitochondrial
signalling, such as peroxisome proliferator-activated
receptor γ coactivator 1α (PGC1α; PPARGC1A) in both
skeletal muscle (Stephens et al. 2010) and adipose tissue
(Chen et al. 2017). However, fasting per se can increase
PGC1αmRNAexpression in rodentmuscle (deLange et al.
2006) – although data in humans do not fully support this
(Tsintzas et al. 2006) – and low carbohydrate availability
augments the physical activity induced increase in PGC1α
mRNAexpression in human skeletalmuscle (Camera et al.
2015). Therefore, it could be that any potential change in
PGC1α with our intermittent fasting protocol was offset
by a difference in the physical activity patterns between
FAST and BFAST groups.
The large (>700 kcal) carbohydrate-rich breakfast
employed in the present studymaypreclude generalisation
to smaller breakfasts differing in composition. However,
the rationale for a large carbohydrate-rich breakfast was
to demonstrate proof-of-principle with a first study
in this area. Furthermore, as an exploratory study of
the molecular responses of adipose tissue to regular
morning fasting versus breakfast consumption, there were
insufficient published data to perform a power calculation
on the outcome variables described in the present study.
Therefore, some outcome variables may be underpowered
and future work should aim to confirm and expand
upon these findings, especially with breakfasts differing
in macronutrient composition.
In conclusion, 6 weeks of extended morning fasting
increases the post-absorptive expression of genes involved
in insulin signalling and lipid turnover, compared to
daily breakfast consumption in lean individuals. Most of
these responses are not observed in obese individuals.
However, extended morning fasting did not alter the
protein content or insulin-stimulated phosphorylation of
Akt, nor the protein content of GLUT4. Therefore, any
potential changes in adipose tissue glucose control with
alterations inmorning feeding patterns are likely to be due
toproteins involved in signalling andGLUT4 translocation
downstream of Akt. Finally, adipose tissue from obese
individuals displays lower rates of insulin-stimulated
glucose uptake than that from lean individuals, which
appears to be proportional to whole-body fat mass and
may represent an adaptive physiological down-regulation
of adipose tissue glucoseuptake inobesity, thereby limiting
the rate of de novo lipid storage.
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